Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 15 - Issue 8 - August, 2003

Feature

Original Contribution
Balloon Sizing of Pulmonary Branch Stenosis: A Useful Method to Guide Stent Implantation
03/14/2012

Ashraf M. Nagm, MD and John W. Moore, MD, MPH

Ashraf M. Nagm, MD and John W. Moore,...
NULL
NULL
NULL
03/14/2012
Journal of Invasive Cardiology
Original Contribution
Contrast-Media Induced Nephropathy in Patients Undergoing Coronary Angiography
08/01/2008

Vitor O. Gomes, MD, Patrícia Blaya, MD, Carlos E. Poli de Figueiredo, MD, PhD, Waldomiro Manfroi, MD, PhD, Paulo Caramori, MD, PhD

Vitor O. Gomes, MD, Patrícia Blaya, ...
In 1942, Pendergrass et al.1 reported renal function impairment associated with the use of radiographic contrast media for the first time. Those authors studied 16 patients who died after undergoing excretory urography. Nine of the 16...
In 1942, Pendergrass et al.1 reported renal function impairment associated with the use of radiographic contrast media for the first time. Those authors studied 16 patients who died after undergoing excretory urography. Nine of the 16...
In 1942, Pendergrass et al.1...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Contrast-Media Induced Nephropathy in Patients Undergoing Coronary Angiography (Part II of II)
08/01/2008
Vitor O. Gomes, MD, Patrícia Blaya, MD, Carlos E. Poli de Figueiredo, MD, PhD, Waldomiro Manfroi, MD, PhD, Paulo Caramori, MD, PhD
Vitor O. Gomes, MD, Patrícia Blaya,...
(PART II of II) 7) Hemodialysis. Lehnert et al.,63 in a randomized study, assessed the prophylactic use of hemodialysis for 3 hours in patients with serum creatinine above 1.4 mg/dl who underwent both cardiac and non-cardiac procedures,...
(PART II of II) 7) Hemodialysis. Lehnert et al.,63 in a randomized study, assessed the prophylactic use of hemodialysis for 3 hours in patients with serum creatinine above 1.4 mg/dl who underwent both cardiac and non-cardiac procedures,...
(PART II of II) 7)...
08/01/2008
Journal of Invasive Cardiology
Case Report
Inoue Balloon Mitral Valvuloplasty in Double-Orifice Mitral Stenosis
08/01/2008
Ping-Han Lo, MD, Jui-Sung Hung, MD, Kean-Wah Lau, MD, *Moo Hyun Kim, MD, †Po-Ming Ku, MD, §Mohammad Krayyem, MD
Ping-Han Lo, MD, Jui-Sung Hung, MD, K...
Double-orifice mitral valve (DOMV) is a rare congenital anomaly characterized by the presence of 2 mitral orifices, each possessing an independent chordal attachment to a papillary muscle.1,2 DOMV may occur as an isolated anomaly or, more...
Double-orifice mitral valve (DOMV) is a rare congenital anomaly characterized by the presence of 2 mitral orifices, each possessing an independent chordal attachment to a papillary muscle.1,2 DOMV may occur as an isolated anomaly or, more...
Double-orifice mitral valve...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Prevention of Radiocontrast-Induced Nephropathy with N-Acetylcysteine in Patients Undergoing <br />
Coronary Angiography
08/01/2008
George M. Tadros, MD, *Elie N. Mouhayar, MD, *Akindolapo O. Akinwande, MD, *Brenda Campbell, RN, **Craig Wood, MS, *James C. Blankenship, MD, *Elias A. Iliadis, MD
George M. Tadros, MD, *Elie N. Mouhay...
Acute transient renal insufficiency after exposure to radiocontrast agents has been well described. The incidence varies among studies depending on the definition and the patient population studied.1 One of the more commonly accepted...
Acute transient renal insufficiency after exposure to radiocontrast agents has been well described. The incidence varies among studies depending on the definition and the patient population studied.1 One of the more commonly accepted...
Acute transient renal...
08/01/2008
Journal of Invasive Cardiology
Patients at Low Risk for Periprocedural Myocardial Infarction Can Be Identified by Assessment Immediately Following Percutaneous
08/01/2008
Ehtisham Mahmud, MD, Kevin D. Shaw, BS, William F. Penny, MD
Ehtisham Mahmud, MD, Kevin D. Shaw, B...
Despite advances in the technical and pharmacologic aspects of percutaneous coronary intervention (PCI), periprocedural myocardial infarction (PPMI) remains a significant complication of the procedure. Previous studies identified clinical...
Despite advances in the technical and pharmacologic aspects of percutaneous coronary intervention (PCI), periprocedural myocardial infarction (PPMI) remains a significant complication of the procedure. Previous studies identified clinical...
Despite advances in the...
08/01/2008
Journal of Invasive Cardiology
Parameters of Left Ventricular Diastolic Function 48 Hours After Coronary Angioplasty and Stent Implantation
08/01/2008
Christiana M. Schannwell, MD, Markus Schneppenheim, MD, Gunnar Plehn, MD, Bodo E. Strauer, MD
Christiana M. Schannwell, MD, Markus...
Over the past 20 years, percutaneous transluminal coronary angioplasty (PTCA) has emerged as the treatment of choice for many patients with atherosclerotic coronary artery disease. With increased experience and technical advances, the...
Over the past 20 years, percutaneous transluminal coronary angioplasty (PTCA) has emerged as the treatment of choice for many patients with atherosclerotic coronary artery disease. With increased experience and technical advances, the...
Over the past 20 years,...
08/01/2008
Journal of Invasive Cardiology
Bivalirudin as a Foundation Anticoagulant in Peripheral Vascular Disease: A Safe and Feasible Alternative for Renal and Iliac In
08/01/2008
David E. Allie, MD, Mitchell D. Lirtzman, MD, Charles H. Wyatt, MD, V. Antoine Keller, MD, Mohamed H. Khan, MD, Muhammad A. Khan, MD, Peter S. Fail, MD, Chris J. Hebert, RT, RCIS, Sonja D. Ellis, MBA, Elena Mitran, MD, Gary Chaisson, RT, RCIS, Samuel Stagg, Jr., MD, Adam A. Allie, MS, Craig M. Walker, MD
David E. Allie, MD, Mitchell D. Lirt...
Over 200,000 peripheral interventions were performed in 1997; this number continues to grow at a rapid pace.1 Peripheral artery disease (PAD), also referred to as peripheral vascular disease (PVD), affects 12–20% of Americans &gt;= 65 years...
Over 200,000 peripheral interventions were performed in 1997; this number continues to grow at a rapid pace.1 Peripheral artery disease (PAD), also referred to as peripheral vascular disease (PVD), affects 12–20% of Americans &gt;= 65 years...
Over 200,000 peripheral...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
Radiocontrast-Induced Nephropathy
08/01/2008
Joseph R. Carver, MD
Joseph R. Carver, MD
Contrast-induced nephropathy (CIN) is a well-recognized complication of angiographic procedures. The incidence varies according to the population studied, the definition applied and the vigilance of the angiographer in measuring post...
Contrast-induced nephropathy (CIN) is a well-recognized complication of angiographic procedures. The incidence varies according to the population studied, the definition applied and the vigilance of the angiographer in measuring post...
Contrast-induced nephropathy...
08/01/2008
Journal of Invasive Cardiology
Commentary
Contrast-Induced Nephropathy: Back to Basics
08/01/2008
Fernando Boccalandro, MD and H. Vernon Anderson, MD
Fernando Boccalandro, MD and H. Verno...
Contrast-induced nephropathy (CIN) represents a significant clinical problem in the United States, where more than 1,000,000 patients undergo cardiac catheterization procedures every year. This makes catheterization the second most frequent...
Contrast-induced nephropathy (CIN) represents a significant clinical problem in the United States, where more than 1,000,000 patients undergo cardiac catheterization procedures every year. This makes catheterization the second most frequent...
Contrast-induced nephropathy...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death&nbsp; Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death&nbsp; Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death&nbsp; Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death&nbsp; Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

June 2003 Volume 15 Issue 8

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement